<i>Interleukin</i>-17 Gene Polymorphisms Contribute to Cancer Risk

<table>OR and 95% CIs for the association between<i> IL-17A</i> rs2275913G&gt;A polymorphism with cancer risk for the GA + AA versus GG model.</table>

Mediators of Inflammation

fig2

Figure 2

Figure 2: <i>Interleukin</i>-17 Gene Polymorphisms Contribute to Cancer Risk 

Mediators of Inflammation

Interleukin-17 Gene Polymorphisms Contribute to Cancer Risk

Figure 2